|
1
|
Taylor RE, Bailey CC, Robinson K, et al:
Results of a randomized study of preradiation chemotherapy versus
radiotherapy alone for non-metastatic medulloblastoma: the
International Society of Paediatric Oncology/United Kingdom
Children’s Cancer Study Group PNET-3 Study. J Clin Oncol.
21:1581–1591. 2003.
|
|
2
|
Zeltzer PM, Boyett JM, Finlay JL, et al:
Metastasis stage, adjuvant treatment, and residual tumor are
prognostic factors for medulloblastoma in children: conclusions
from the Children’s Cancer Group 921 Randomized Phase III Study. J
Clin Oncol. 17:832–845. 1999.PubMed/NCBI
|
|
3
|
Kozarsky KF and Wilson JM: Gene therapy:
adenovirus vectors. Curr Opin Genet Dev. 3:499–503. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pützer BM, Bramson JL, Addison CL, et al:
Combination therapy with interleukin-2 and wild-type p53 expressed
by adenoviral vectors potentiates tumor regression in a murine
model of breast cancer. Hum Gene Ther. 9:707–718. 1998.PubMed/NCBI
|
|
5
|
Nishi M, Kumar NM and Gilula NB:
Developmental regulation of gap junction gene expression during
mouse embryonic development. Dev Biol. 146:117–130. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Houghton FD: Role of gap junctions during
early embryo development. Reproduction. 129:129–135. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vinken M, Vanhaecke T, Papeleu P, et al:
Connexins and their channels in cell growth and cell death. Cell
Signal. 18:592–600. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Trosko JE and Chang CC: Modulation of
cell-cell communication in the cause and
chemoprevention/chemotherapy of cancer. Biofactors. 12:259–263.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mesnil M, Piccoli C, Tiraby G, et al:
Bystander killing of cancer cells by herpes virus thymidine kinase
gene is mediated by connexins. Proc Natl Acad Sci USA.
93:1831–1835. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Elshami AA, Saavedra A, Zhang H, et al:
Gap junctions play a role in the ‘bystander effect’ of the herpes
simplex thymidine kinase/ganciclovir system in vitro. Gene Ther.
3:85–92. 1996.
|
|
11
|
Alexander DB and Goldberg GS: Transfer of
biologically important molecules between cells through gap junction
channels. Curr Med Chem. 10:2045–2058. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamasaki H: Gap junction intercellular
communication carcinogenesis. Carcinogenesis. 11:1051–1058. 1990.
View Article : Google Scholar
|
|
13
|
Yamasaki H, Mesnil M, Omori Y, et al:
Intercellular communication and carcinogenesis. Mutat Res.
333:181–188. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou DR, Zhou YC, Cui GH, et al: Gossypol
repressed the gap junctional intercellular communication between
Sertoli cells by decreasing the expression of Connexin43. Toxicol
In Vitro. 22:1719–1725. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rosolen A, Frascella E, di Francesco C,
Todesco A, et al: In vitro and in vivo antitumor effect of
retrovirus mediated herpes simplex thymidine kinase gene transfer
in human medulloblastoma. Gene Ther. 5:113–120. 1998. View Article : Google Scholar
|
|
16
|
Huang RP, Hossain MZ, Huang R, et al:
Connexin 43 (cx43) enhances chemotherapy-induced apoptosis in human
glioblastoma cells. Int J Cancer. 92:130–138. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pu K, Li SY, Gao Y, et al: Bystander
effect in suicide gene therapy using immortalized neural stem cells
transduced with herpes simplex virus thymidine kinase gene on
medulloblastoma regression. Brain Res. 1369:245–252. 2011.
View Article : Google Scholar
|
|
18
|
Miyashita T and Reed JC: Bcl-2 oncoprotein
blocks chemotherapy-induced apoptosis in a human leukemia cell
line. Blood. 81:151–157. 1993.PubMed/NCBI
|
|
19
|
Piche A, Grim J, Rancourt C, et al:
Modulation of Bcl-2 protein levels by an intracellular anti-Bcl-2
single-chain antibody increases drug-induced cytotoxicity in the
breast cancer cell line MCF-7. Cancer Res. 58:2134–2140.
1998.PubMed/NCBI
|
|
20
|
Reed JC, Miyashita T, Takayama S, et al:
BCL-2 family proteins: regulators of cell death involved in the
pathogenesis of cancer and resistance to therapy. J Cell Biochem.
60:23–32. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jimenez T, Fox WP, Naus CC, et al:
Connexin over-expression differentially suppresses glioma growth
and contributes to the bystander effect following HSV-thymidine
kinase gene therapy. Cell Commun Adhes. 13:79–92. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang A, Wang Qy, Han Z, et al:
Relationship between the expression of connexin43 and bystander
effect of suicide gene therapy in ovarian cancer. J Huazhong Univ
Sci Technolog Med Sci. 24:476–479. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Carystinos GD, Alaoui-Jamali MA, Phipps J,
et al: Upregulation of gap junctional intercellular communication
and connexin 43 expression by cyclic-AMP and all-trans-retinoic
acid is associated with glutathione depletion and chemosensitivity
in neuroblastoma cells. Cancer Chemother Pharmacol. 47:126–132.
2001. View Article : Google Scholar
|
|
24
|
Chen TC, Hinton DR, Zidovetzki R and
Hofman FM: Upregulation of the cAMP/PKA pathway inhibits
proliferation, induces differentiation, and leads to apoptosis in
malignant gliomas. Lab Invest. 78:165–174. 1998.PubMed/NCBI
|
|
25
|
Goodenough DA, Goliger JA and Paul DL:
Connexins, connexons, and intercellular communication. Annu Rev
Biochem. 65:475–502. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Laird DW, Puranam KL and Revel JP:
Turnover and phosphorylation dynamics of connexin43 gap junction
protein in cultured cardiac myocytes. Biochem J. 273:67–72.
1991.PubMed/NCBI
|
|
27
|
Granot I and Dekel N: Phosphorylation and
expression of connexin-43 ovarian gap junction protein are
regulated by luteinizing hormone. J Biol Chem. 269:30502–30509.
1994.PubMed/NCBI
|
|
28
|
Burt JM and Spray DC: Ionotropic agents
modulate gap junctional conductance between cardiac myocytes. Am J
Physiol. 254:H1206–H1210. 1988.PubMed/NCBI
|
|
29
|
Godwin AJ, Green LM, Walsh MP, et al: In
situ regulation of cell-cell communication by the cAMP-dependent
protein kinase and protein kinase C. Mol Cell Biochem.
127–128:293–307. 1993.PubMed/NCBI
|
|
30
|
Vile RG, Nelson JA, Castleden S, et al:
Systemic gene therapy of murine melanoma using tissue specific
expression of the HSVtk gene involves an immune component.
Cancer Res. 54:6228–6234. 1994.PubMed/NCBI
|
|
31
|
Caruso M, Panis Y, Gagandeep S, et al:
Regression of established macroscopic liver metastases after in
situ transduction of a suicide gene. Proc Natl Acad Sci USA.
90:7024–7028. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Samejima Y and Meruelo D: ‘Bystander
killing’ induces apoptosis and is inhibited by forskolin. Gene
Ther. 2:50–58. 1995.
|
|
33
|
Freeman SM, Abboud CN, Whartenby KA, et
al: The ‘bystander effect’: tumor regression when a fraction of the
tumor mass is genetically modified. Cancer Res. 53:5274–5283.
1993.
|
|
34
|
Ram Z, Walbridge S, Shawker T, et al: The
effect of thymidine kinase transduction and ganciclovir therapy on
tumor vasculature growth of 9L gliomas in rats. J Neurosurg.
81:256–260. 1994. View Article : Google Scholar : PubMed/NCBI
|
